Skip to main content
Skip to navigation

Supplements

Guidelines in Practice supplements provide expert opinion articles on a range of clinical and commissioning areas. Our supplement range includes the following types: Product Review; Guidance Update; Local Implementation. Items may contain pharmaceutical promotional information.

The treatment of giant cell arteritis (GCA)—a focus on RoACTEMRA® (tocilizumab) in line with current guidelines

Commissioned by Roche Products Limited and Chugai Pharma UK Limited

Switching appropriate patients with type 2 diabetes to alogliptin from existing DPP-4 inhibitors: experience and outcomes from three Clinical Commissioning Groups and Local Health Boards

Commissioned by Takeda UK Ltd

Choosing a dipeptidyl peptidase-4 inhibitor in adults with type 2 diabetes and co‑morbidities

Commissioned by Boehringer Ingelheim Limited

How should inhaled steroids be used in the management of asthma in adults within a primary care setting?

Supported by an educational grant from CIPLA EU Ltd

The re-usable Respimat® Soft Mist™ inhaler

Commissioned by Boehringer Ingelheim Limited

Managing common skin conditions without antibiotics

Funded by Galderma UK Ltd

Guideline for the managed introduction of biosimilar basal insulin

Supported by an educational grant from Mylan